The Belt and Road: Cooperation, Harmony and Win-Win
products

Products

Sitagliptin Phosphate CAS:654671-78-0 Manufacturer Supplier

Sitagliptin Phosphate is the first novel dipeptidyl peptidase IV inhibitor from Merck for the treatment of type 2 diabetes without weight gain and the incidence of hypoglycemia was similar to placebo. Sitagliptin acts by enhancing the body’s incretin system, which helps to regulate glucose by affecting β and α cells in the pancreas.


Product Detail

Product Tags

Application and Effect

Sitagliptin Phosphate is a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.Sitagliptin phosphate is dipeptidyl peptidase Ⅳ(DDP-4) inhibitor class of drugs developed by the German Merck company and firstly obtained the US Food and Drug Administration approval for the treatment of type 2 diabetes, is a new antidiabetic drug, can improve the body's own ability to reduce high blood glucose levels, and the relatively increase naturally occurring incretin by inhibiting the activity of this enzyme, including the levels of glucagon-like peptide 1 and glucose-dependent insulinotropic peptide, thereby triggering the pancreas to improve insulin production and stop glucose production in liver, and ultimately reduce the clinical effect of blood glucose concentration. 

Product Sample

图片364(1)
图片365(1)

Product Packing:

图片338(1)

Additional Information:

Composition C16H15F6N5O.H3PO4
Assay 99%
Appearance White to Off-White powder
CAS No. 654671-78-0
Packing 25KG
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

  • Previous:
  • Next:

  • Write your message here and send it to us